- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Long-term data confirm stenting's cognitive benefit
For the first time, long-term data show sustained cognitive improvement at one year in patients who have undergone carotid stenting, according to a report from the 2007 International Symposium on Endovascular Therapy.
For the first time, long-term data show sustained cognitive improvement at one year in patients who have undergone carotid stenting, according to a report from the 2007 International Symposium on Endovascular Therapy. What's more interesting is that many asymptomatic patients in the study also showed improved cognitive functions following stenting.
This finding has led investigators to question the very notion of labeling these patients who are asymptomatic. The government currently reimburses only for symptomatic patients undergoing carotid stenting, according to Dr. Rodney Raabe, an interventional radiologist with Inland Vascular Institute in Spokane, WA.
"Symptomatic carotid stenosis may need to be redefined in the future to include functional deficits," Raabe said. "Perhaps potential neurocognitive improvement will be considered in carotid stenosis treatment."
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
